LabGenomics Co., Ltd. (KOSDAQ:084650)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,293.00
+19.00 (1.49%)
Apr 3, 2026, 3:30 PM KST
Market Cap95.99B -47.2%
Revenue (ttm)88.16B +2.6%
Net Income-64.37B
EPS-867.00
Shares Out74.24M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume185,424
Average Volume364,940
Open1,285.00
Previous Close1,274.00
Day's Range1,270.00 - 1,310.00
52-Week Range1,268.00 - 3,285.00
Beta0.12
RSI38.05
Earnings DateApr 3, 2026

About LabGenomics

LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2002
Employees 142
Stock Exchange KOSDAQ
Ticker Symbol 084650
Full Company Profile

Financial Performance

In 2025, LabGenomics's revenue was 88.16 billion, an increase of 2.63% compared to the previous year's 85.90 billion. Losses were -64.37 billion, 170.5% more than in 2024.

Financial Statements